Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal–Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy
- 24 July 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (33) , 36906-36916
Abstract
Efficient and cancer cell targeted delivery of photosensitizer (PS) and therapeutic protein have great potentiality for improving the anticancer effects. Herein, zeolitic imidazolate framework-8 (ZIF-8) nanoparticle, one of the most attractive metal-organic framework materials, was used for co-encapsulating the chlorin e6 (Ce6, a potent PS) and cytochrome c (Cyt c, a protein apoptosis inducer), then the nanoparticle was subsequently decorated with hyaluronic acid (HA) shell to form cancer cell active targeted nanoplatform (Ce6/Cyt [email protected]/HA). The in vitro and in vivo experiments show the cancer cell targeting capability and pH-responsive decomposition and release behavior of Ce6/Cyt [email protected]/HA. Upon light irradiation, the released Ce6 produced cytotoxic reactive oxygen species (ROS) for photodynamic therapy. Meanwhile, the released Cyt c induced programmed cell death for protein therapy. Furthermore, the Cyt c worked normally under hypoxia condition and could decompose H2O2 to O2 (with peroxidase/catalase like activity), resulting in synergistically improved therapeutic efficiency. These small molecules and protein co-delivery nanoplatforms would promote the development of complementary and synergetic modes for biomedical applications.Keywords
Funding Information
- China Postdoctoral Science Foundation (2019M652241)
- National Natural Science Foundation of China (21605021, 61875141)
- Fujian Provincial Health Commission (2019-WJ-12)
- Fujian Province (2018-CX-49, 2018Y9119)
- Education Commission of Fujian Province (2019-WJ-12)
This publication has 35 references indexed in Scilit:
- A Phototheranostic Strategy to Continuously Deliver Singlet Oxygen in the Dark and Hypoxic Tumor MicroenvironmentAngewandte Chemie International Edition, 2020
- Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination TherapyACS Applied Materials & Interfaces, 2019
- Liposomal formulations of photosensitizersBiomaterials, 2019
- Innovative Strategies for Hypoxic‐Tumor Photodynamic TherapyAngewandte Chemie International Edition, 2018
- pH/hypoxia programmable triggered cancer photo-chemotherapy based on a semiconducting polymer dot hybridized mesoporous silica frameworkChemical Science, 2018
- Light-Enhanced Hypoxia-Response of Conjugated Polymer Nanocarrier for Successive Synergistic Photodynamic and Chemo-TherapyACS Applied Materials & Interfaces, 2018
- Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated TherapyACS Nano, 2017
- Nanoparticles in Photodynamic TherapyChemical Reviews, 2015
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Photodynamic therapy for cancerNature Reviews Cancer, 2003